doi:10.3390/ijms231710136 Segarra M, Aburto MR, Acker-Palmer A
Although the GIP and GIP receptor system is known to promote energy assimilation and contribute to obesity [26], the fact that a dual GIP/GLP-1R agonist exhibited stronger anti-obesity effects than GLP-1RAs alone was unexpected
Model the financial impact
If you experience any side effects, including skin reactions, you can report them directly to the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk or via the Yellow Card app)
has received honoraria and/or lecture fees from AstraZeneca, Boehringer Ingelheim, Bristol-Meyers Squibb, Eli Lilly, Intarcia Therapeutics, Johnson & Johnson, Merck Sharp & Dohme, Novartis, Novo Nordisk, and Sanofi Aventis
One group was given a diet supplemented with L-carnitine while another group received a diet without supplemental L-carnitine